Drug Approval | September 28, 2022
EDQM grants CEP certificate to Supriya Lifescience for Diphenhydramine Hydrochloride
This will be an added advantage for Supriya Lifescience Limited in the European market.
This will be an added advantage for Supriya Lifescience Limited in the European market.
The Bulk Drug Parks to be developed under the scheme will provide common infrastructure facilities at one place thereby creating a robust ecosystem for the bulk drug manufacturing in the country and also reducing manufacturing cost significantly
75 inter-disciplinary, multi-institutional grants would be supported for high-risk, ambitious research ideas, milestones-driven collaborative research in all domain areas of the biotech sector
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Nocria’s hand-held device uses gentle, controlled puffs of air in the ears for treating migraine attacks
Covaxin was earlier approved for children 12-18 years of age
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients
Subscribe To Our Newsletter & Stay Updated
